Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | RASSF9 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of RASSF9 mRNA | CTD | PMID:21795739 | RASSF9 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | Progesterone inhibits the reaction [Estradiol results in increased expression of RASSF9 mRNA] | CTD | PMID:21795739 | RASSF9 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RASSF9 mRNA | CTD | PMID:32109520 and PMID:34747641 | RASSF9 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RASSF9 mRNA | CTD | PMID:33387578 | RASSF9 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of RASSF9 mRNA | CTD | PMID:30851411 | RASSF9 | Human | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:23196670 | RASSF9 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Rassf9 (Mus musculus) | 6480464 | bisphenol S results in increased expression of RASSF9 mRNA | CTD | PMID:30951980 | RASSF9 | Human | ammonium chloride | affects expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of RASSF9 mRNA | CTD | PMID:16483693 | RASSF9 | Human | benzo[a]pyrene | multiple interactions | ISO | Rassf9 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RASSF9 mRNA] | CTD | PMID:22228805 | RASSF9 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of RASSF9 5' UTR | CTD | PMID:27901495 | RASSF9 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of RASSF9 promoter | CTD | PMID:27901495 | RASSF9 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of RASSF9 mRNA | CTD | PMID:22316170 | RASSF9 | Human | bisphenol A | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of RASSF9 mRNA | CTD | PMID:25181051 more ... | RASSF9 | Human | bisphenol A | increases expression | ISO | Rassf9 (Mus musculus) | 6480464 | bisphenol A results in increased expression of RASSF9 mRNA | CTD | PMID:32156529 | RASSF9 | Human | bisphenol A | decreases methylation | ISO | Rassf9 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of RASSF9 promoter | CTD | PMID:27312807 | RASSF9 | Human | bisphenol F | increases expression | ISO | Rassf9 (Mus musculus) | 6480464 | bisphenol F results in increased expression of RASSF9 mRNA | CTD | PMID:30951980 | RASSF9 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of RASSF9 mRNA | CTD | PMID:26079696 | RASSF9 | Human | carbon nanotube | decreases expression | ISO | Rassf9 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of RASSF9 mRNA | CTD | PMID:25554681 | RASSF9 | Human | choline | multiple interactions | ISO | Rassf9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASSF9 mRNA | CTD | PMID:20938992 | RASSF9 | Human | Cuprizon | increases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of RASSF9 mRNA | CTD | PMID:26577399 | RASSF9 | Human | diethylstilbestrol | increases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in increased expression of RASSF9 mRNA | CTD | PMID:21658437 | RASSF9 | Human | diuron | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of RASSF9 mRNA | CTD | PMID:21551480 | RASSF9 | Human | endosulfan | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of RASSF9 mRNA | CTD | PMID:29391264 | RASSF9 | Human | flavonoids | increases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of RASSF9 mRNA | CTD | PMID:18035473 | RASSF9 | Human | folic acid | multiple interactions | ISO | Rassf9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASSF9 mRNA | CTD | PMID:20938992 | RASSF9 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of RASSF9 mRNA | CTD | PMID:20655997 | RASSF9 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of RASSF9 protein | CTD | PMID:37730182 | RASSF9 | Human | furan | increases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | furan results in increased expression of RASSF9 mRNA | CTD | PMID:27387713 | RASSF9 | Human | inulin | multiple interactions | ISO | Rassf9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RASSF9 mRNA | CTD | PMID:36331819 | RASSF9 | Human | L-methionine | multiple interactions | ISO | Rassf9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASSF9 mRNA | CTD | PMID:20938992 | RASSF9 | Human | Licochalcone B | decreases expression | EXP | | 6480464 | licochalcone B results in decreased expression of RASSF9 mRNA | CTD | PMID:33647349 | RASSF9 | Human | methamphetamine | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Methamphetamine results in decreased expression of RASSF9 mRNA | CTD | PMID:19564919 | RASSF9 | Human | methamphetamine | multiple interactions | ISO | Rassf9 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of RASSF9 mRNA | CTD | PMID:19564919 | RASSF9 | Human | Muraglitazar | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | muraglitazar results in decreased expression of RASSF9 mRNA | CTD | PMID:21515302 | RASSF9 | Human | N-nitrosodiethylamine | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in decreased expression of RASSF9 mRNA | CTD | PMID:20360939 | RASSF9 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of RASSF9 mRNA | CTD | PMID:24768652 and PMID:25583101 | RASSF9 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RASSF9 mRNA | CTD | PMID:26690555 and PMID:29067470 | RASSF9 | Human | paracetamol | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of RASSF9 mRNA | CTD | PMID:33387578 | RASSF9 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Rassf9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RASSF9 mRNA | CTD | PMID:36331819 | RASSF9 | Human | pirinixic acid | increases expression | ISO | Rassf9 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of RASSF9 mRNA | CTD | PMID:20813756 | RASSF9 | Human | progesterone | multiple interactions | EXP | | 6480464 | Progesterone inhibits the reaction [Estradiol results in increased expression of RASSF9 mRNA] | CTD | PMID:21795739 | RASSF9 | Human | progesterone | decreases expression | ISO | Rassf9 (Mus musculus) | 6480464 | Progesterone results in decreased expression of RASSF9 mRNA | CTD | PMID:22238285 | RASSF9 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of RASSF9 mRNA | CTD | PMID:30851411 | RASSF9 | Human | SCH 23390 | multiple interactions | ISO | Rassf9 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of RASSF9 mRNA | CTD | PMID:19564919 | RASSF9 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of RASSF9 mRNA | CTD | PMID:25895662 | RASSF9 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of RASSF9 mRNA and Silicon Dioxide results in increased expression of RASSF9 mRNA | CTD | PMID:23806026 and PMID:25351596 | RASSF9 | Human | sotorasib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RASSF9 mRNA | CTD | PMID:36139627 | RASSF9 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of RASSF9 mRNA | CTD | PMID:31533062 | RASSF9 | Human | thalidomide | decreases expression | ISO | Rassf9 (Mus musculus) | 6480464 | Thalidomide results in decreased expression of RASSF9 mRNA | CTD | PMID:26217789 | RASSF9 | Human | titanium dioxide | decreases expression | ISO | Rassf9 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of RASSF9 mRNA | CTD | PMID:23557971 | RASSF9 | Human | trametinib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RASSF9 mRNA | CTD | PMID:36139627 | RASSF9 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of RASSF9 mRNA | CTD | PMID:24935251 | RASSF9 | Human | troglitazone | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | troglitazone results in decreased expression of RASSF9 mRNA | CTD | PMID:21515302 | RASSF9 | Human | vinclozolin | decreases expression | ISO | Rassf9 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of RASSF9 mRNA | CTD | PMID:22615374 | |